Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. - Wikidata - wikimedia - TriplyDB

Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.

Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.

http://www.wikidata.org/entity/Q35760428

about

Current trends in inflammatory bowel disease: the natural history Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools.eHealth for inflammatory bowel disease self-management - the patient perspective.Evaluation of "top-down" treatment of early Crohn's disease by double balloon enteroscopy.Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies.Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies.Old-age inflammatory bowel disease onset: a different problem?Immunoproteomic to identify antigens in the intestinal mucosa of Crohn's disease patients.Metabolic syndrome frequency in inflammatory bowel diseases.Crohn's disease: why the disparity in mortality?Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.First diagnosis of inflammatory bowel disease in a 91-year-old man Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis.How expensive is inflammatory bowel disease? A critical analysis Looking in the mouth for Crohn's disease.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study.Anti-adhesion molecule therapy for inflammatory bowel disease Systematic review with meta-analysis: inflammatory bowel disease in the elderly.Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature.The epidemiology of inflammatory bowel disease.Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Québec, Canada.Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study.The emerging global epidemic of paediatric inflammatory bowel disease--causes and consequences.Development of a Novel Predictive Model for the Clinical Course of Crohn's Disease: Results from the CONNECT Study.The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation.Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study.Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.Suboptimal breastfeeding in the United States: Maternal and pediatric health outcomes and costs.Clinical course of Crohn's disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005-2009.Do clinical factors help to predict disease course in inflammatory bowel disease?Current directions of biologic therapies in inflammatory bowel disease.Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL).Inflammatory bowel disease of the elderly: a wake-up call.Findings from the European collaborative inflammatory bowel disease database.Phenotype at diagnosis predicts recurrence rates in Crohn's disease.Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.

P2860

Q24629009-FAEA3004-D6F1-4504-A4DF-48A81B5700C8 Q33446999-012F6842-5E6C-44C1-959D-AF11D1240EE0 Q33454966-FECA458B-1E87-493F-B982-A116EFD42175 Q34367007-5F774164-AA9A-480E-A35C-08C19F468677 Q34609514-240BCCF0-D761-4B8C-9F37-B9A25FB10289 Q35030705-62520D3B-6C05-4869-9B9B-309926CBA483 Q35065322-161B7CC4-32E7-4BE5-B887-EDDFF856B0FD Q35072537-0C0ACE47-5774-4B6C-8DC7-57B243E74D40 Q35564312-F30734BE-368C-4A4F-B5F1-F7906DD389F6 Q35760407-E84BACAB-70AC-4A7D-BA96-7A1D45351E3B Q36043446-0300A81F-8068-4FF7-987A-6EEA73EFA89B Q36131710-DB3414DC-10E7-4CDA-A179-2FE16F2CF52A Q36144464-87B73A77-B3B5-410D-9BA4-CA0A774CCB6C Q36551411-879223EC-46DE-40E6-85AB-4DFD2AA7C326 Q36677630-6C5143AB-D68E-4EBC-8E8A-C36156E1494F Q37335250-71428A01-98F8-43D9-B6C4-9A56886D2E1F Q37586360-297109A3-B860-40FA-88EC-3463FA95EDA2 Q37814549-1D4E69FC-C531-4EEE-9572-27ED8C6F751D Q37822501-35B715F0-E7DA-4B40-97D3-F446402C9ED7 Q37823325-6DEE1713-6FBB-46B0-AD3D-DE919CC18AA3 Q38176953-346617D9-7F4C-401D-A282-B91089D950EB Q38222053-570CD753-8F6F-4514-9435-23A0A43B7D19 Q38357796-1B6D1094-A509-4862-B2C4-90BB1F1A0824 Q38411770-1F399434-01B2-4C0A-AA7B-B3895A9D49E1 Q38459143-F9FFC6A8-1FC1-4AE3-BF58-0A283C393EAC Q38583927-0969DCA2-9921-41AC-9378-27B0111ABAA0 Q38836663-A9CD2879-3E0F-4DC8-BE58-5958ADDC0058 Q39308885-6AF9545E-DCF9-4026-8092-288D4F97EE0D Q39380756-3143CCAD-0442-420B-8DC2-EDA2F5CDFF14 Q40254052-B6FA9C8C-054E-4F31-876A-02CB2C61F003 Q40534494-22A42CC7-AF8B-48FC-B39B-AEBB8B1F989F Q40579809-5F8A68C2-0E7C-44E6-BD5B-E8B002DC63F2 Q40884082-CBC53F8B-0E90-412E-BECC-771F5F66F61F Q41174352-B505AA3B-6962-4947-91B8-33BAC24EA52F Q41692244-B015679A-1429-4191-8550-7952B0BEB254 Q42019607-DA7A38F5-E964-433C-8236-4EE15F83FEC8 Q42047853-0AAF8694-4835-4D8A-A390-206AB5BE2695 Q42844583-86023A9D-6CF8-4096-B1E5-5DD8D0E8E4FF Q43263384-D950F472-D38A-43BC-89E0-80736BE63C8F Q45905337-93AB6BD6-1C90-497C-95D8-C60C2E77F1C8

P2860

Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.

http://www.wikidata.org/entity/Q35760428

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Crohn's disease: increased mor ...... -wide population based cohort.

@ast

Crohn's disease: increased mor ...... -wide population based cohort.

@en

type

label

Crohn's disease: increased mor ...... -wide population based cohort.

@ast

Crohn's disease: increased mor ...... -wide population based cohort.

@en

prefLabel

Crohn's disease: increased mor ...... -wide population based cohort.

@ast

Crohn's disease: increased mor ...... -wide population based cohort.

@en

P1433

Q35760428-F69DA1E9-FF46-4DA2-AEED-E0A575E45369

P1476

Q35760428-C6F4178B-0D9A-45E8-B855-76240B4E846A

P2093

Q35760428-166E0AB1-FF7E-44D4-9848-3815EB355F00

Q35760428-1D3F2EB7-6D27-44EB-8911-8CE148C50680

Q35760428-2629277F-A200-415B-AA3F-253BFE1DE114

Q35760428-50CF9B37-EE0F-4E15-9A82-12D079E56793

Q35760428-518BDB96-F15D-4B08-A3BA-BE5DC7603F60

Q35760428-66DE3E5C-687D-46B2-BB40-2E2FD434B545

Q35760428-75C2A33F-8727-48B7-9DDA-010BBB1BFE21

Q35760428-86F42C3E-0979-42DA-AC59-6E4F4AA27BD0

Q35760428-8F3DCC04-6B1B-451F-A0C4-9ED601C80013

Q35760428-909B5636-6EC0-49ED-9984-01206077FD85

P2860

Q35760428-02C9E1B3-3B27-404C-9B51-20B12C13E6E7

Q35760428-046B8437-F98B-43B3-8378-549058B131A2

Q35760428-23833699-78B8-49D1-B82A-E2EBC468B559

Q35760428-23DA402C-83F9-4EC0-816C-29B5FA4B29BA

Q35760428-294EAA59-0F85-45DC-A02F-EBAC2DF6E0C3

Q35760428-3EB508FC-8718-4059-A2AE-B04B69673635

Q35760428-53CB1A79-7605-4632-8ED7-6B8AE0645419

Q35760428-55A415E7-DA20-4662-9416-D0068C1902F7

Q35760428-583794CF-D777-447A-9077-32C92846271D

Q35760428-5BF31E64-CE64-4805-95C5-707232B86ED5

P304

Q35760428-8BF0A38C-1F55-4683-AB7F-6798367F7111

P31

Q35760428-3248E92D-278D-4AF6-B71D-DA5FF79F16B7

P356

Q35760428-8940F688-2DF7-4E83-B78E-BE7ADDFE55CD

P407

Q35760428-7CFF4A8A-AEC7-4DB4-97F2-5A244597380C

P433

Q35760428-E41B3A76-6561-499B-82C4-C27AFDEA9019

P478

Q35760428-E375BF8A-57A1-4FD7-9BF5-5750995CFAB7

P50

Q35760428-1C2AD556-ED53-46FE-BAD7-19885AA4F625

Q35760428-7E3A6252-F30F-46EA-BBE2-F05FDE7F45D8

Q35760428-85C7EDC0-1A2A-43A8-A020-991BD4D75C00

Q35760428-DB59196A-E1BF-49B0-B4CA-43AC46C4F4BC

P577

Q35760428-1A581A7B-95BF-408B-AC46-23F22B7B64AC

P5875

Q35760428-C22CD3C0-52ED-42DB-91DF-29FD742A952E

P698

Q35760428-0881E99C-3375-43FB-8EC4-3A400E87DA8C

P921

Q35760428-DDCBDE8E-D6CE-45BE-90F4-7893D549EA0B

P932

Q35760428-A640B671-0793-4E7A-A9D4-6D7E4869ABBD

P356

GUT.2005.072793

P1433

P1476

Crohn's disease: increased mor ...... -wide population based cohort.

@en

P2093

C Limonard

http://www.w3.org/2001/XMLSchema#string

C O'Morain

http://www.w3.org/2001/XMLSchema#string

E Monteiro

http://www.w3.org/2001/XMLSchema#string

E Tsianos

http://www.w3.org/2001/XMLSchema#string

European Collaborative study group on Inflammatory Bowel Disease (EC-IBD)

http://www.w3.org/2001/XMLSchema#string

F L Wolters

http://www.w3.org/2001/XMLSchema#string

I A Mouzas

http://www.w3.org/2001/XMLSchema#string

J Sijbrandij

http://www.w3.org/2001/XMLSchema#string

L J Schouten

http://www.w3.org/2001/XMLSchema#string

L Riis

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

Systematic review: has disease outcome in Crohn's disease changed during the last four decades?

Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates.

Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital.

Mortality from Crohn's disease in Leicestershire, 1972-1989: an epidemiological community based study.

Course and prognosis of Crohn's disease.

General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study

Mortality in Crohn's disease--a clinical analysis.

Survival rate in Crohn's disease and ulcerative colitis.

Geographic variation in the incidence of and mortality from inflammatory bowel disease.

P304

510-518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.072793

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Séverine Vermeire

Gino Fornaciari

P577

2005-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7610978

http://www.w3.org/2001/XMLSchema#string

P698

16150857

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

1856169

http://www.w3.org/2001/XMLSchema#string